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Maintenance of antigen-specific immunological memory through
variable regions of heavy and light chains of anti-idiotypic antibody
Introduction
Immunological memory is an intrinsic property of the
immune system. Factors governing the generation and
perpetuation of immunological memory have been the
subject of many investigations but these have not des-
cribed any clear-cut mechanism to account for its per-
petuation. The immune system of an individual can make
millions of different kinds of antibodies. Each antibody
can in turn be the target of other antibodies that recog-
nize its unique molecular determinants. Idiotypes (sets
of idiotopes) are determinants expressed in the variable
region of the antibody molecules and T-cell receptors.
Jerne’s Network theory predicts that idiotypic and anti-
idiotypic interactions constitute an immune network that
is involved in the regulation of the immune responses.1
A mechanism has been proposed2 that explains the per-
petuation of B-cell immunological memory indefinitely
without requiring the presence of long-living memory
cells or persisting antigen. The hypothesis combines the
essential features of Burnet’s clonal selection theory and
Jerne’s network hypothesis and considers both B-cell
and T-cell memory. According to this hypothesis, the
key event for generation of a memory response is the
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Summary
Immunological memory is characterized by a quick and enhanced
immune response after re-exposure to the same antigen. To explain the
mechanism involved in generation and maintenance of immunological
memory, we had earlier proposed a hypothesis involving the relay of
memory by idiotypic and anti-idiotypic B cells. The peptidomimic present
in the hypervariable region of anti-idiotypic antibody was hypothesized to
carry forward immunological memory. In the present work, we provide
evidence supporting a role for the anti-idiotypic antibody in eliciting anti-
gen-specific B-cell and T-cell responses. Employing the idiotypic monoclo-
nal antibody (Ab1) specific for haemagglutinin (H) protein of rinderpest
virus, Ab2b was generated, which possesses an internal image of the H
protein in the region between amino acids 527 and 556. We demonstrate
that antigen-specific memory is perpetuated by immunization with Ab2,
as shown by maintenance of antigen-specific T-cell responses upon
restimulation in vitro of Ab2 immune splenocytes by antigen-presenting
cells expressing H protein or pulsed with H-protein-derived peptides. We
have also shown that boosting with antigen-specific anti-idiotypic B cells
generates a memory response in antigen-primed mice. Evidence has been
provided for the existence of an antigen-specific B-cell idiotypic network
in the body that supports the perpetuation of immunological memory as
proposed in the relay hypothesis.
Keywords: anti-idiotypic-B cells; idiopeptide; immunological memory;
peptidomimics; relay hypothesis
Abbreviations: Ab, antibody; APC, antigen-presenting cell; APL, altered peptide ligand; BCR, B-cell receptor; CDR,
complementarity-determining region; CTL, cytotoxic T lymphocyte; DC, dendritic cell; ELISA, enzyme-linked immunosorbent
assay; H protein, haemagglutinin protein; Id, idiotype; IFN-c, interferon-c; Ig, immunoglobulin; IL, interleukin; MHC, major
histocompatibility complex; OD, optical density; VH/VL, variable region of heavy/light chains of immunoglobulin.
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interaction of idiotypic (antigen-specific cells or Burnet
cells) and anti-idiotypic cells (cells that are reactive to idi-
otypic determinant or Jerne cells). These idiotype and
anti-idiotype B cells mutually stimulate and clonally
expand, with either specific or bystander T-cell help. The
anti-idiotypic cells carry a peptidomimic, which drives
the memory response further by triggering idiotypic
memory T cells. Because B cells can present antigen,3 they
present ‘apparently foreign’ idiopeptides to T cells. The
idiopeptides of de novo synthesized antibody are presented
to CD8+ T cells through class I major histocompatibility
complex (MHC), which recognizes the idiopeptide-
presenting cells as targets and regulates their population.
The recycling of immunoglobulins from the surface to the
endosomal compartment of B cells leads to the presenta-
tion of idiopeptides to CD4+ T cells by class II MHC.
Even if the majority of the clonally expanded cells die as
a result of lack of stimulation, cytotoxic T-lymphocyte
(CTL) lysis or for other reasons, the surviving cells are
able to carry forward the memory. This mechanism also
provides a means for affinity maturation through the
idiotypic selection of somatically mutated high-affinity
cells or those from the naive pool.
There is experimental evidence for the relay hypothesis
descsribed above, and it has been shown that the idio-
typic and anti-idiotypic B cells are generated in the same
animal after immunization with antigen4 and that T cells
are involved in the idiotype–anti-idiotype B-cell network.5
Anti-idiotypic B cells, which carry peptidomimic in their
antigenic determinants, are thought to play a crucial role
in the maintenance and regulation of B-cell and T-cell
memory, as originally proposed in the relay hypothesis. A
role for serum immunoglobulins in the perpetuation of
immunological memory has also been proposed.6
The immune system is a functional idiotypic network
and anti-idiotypic antibodies are components of the nor-
mal immune system.7–10 It has been proposed that one of
the peripheral regulatory mechanisms involves recogni-
tion of internal image by the idiotypic determinants of
specific antibodies or T lymphocytes, which regulate the
immune response to both foreign and self-antigens.1,2,11
Anti-idiotypes have long been used as priming agents or
sole immunogens, in conjunction with antigen or coupled
with tetanus toxoid, interleukin-2 (IL-2) or granulo-
cyte–macrophage colony-stimulating factor,12,13 for the
production of antibodies reactive to virus, bacteria or
tumour antigens. It has also been shown that part of
transplacental immunoglobulin G (IgG) antibodies also
contain anti-idiotypic antibodies that might prime the
immune system of the offspring.14 However, the role of
anti-idiotypic antibodies in the long-term perpetuation
of antigen-specific immunological memory in the absence
of an antigenic stimulus has not been established.
In the present work, we describe the generation and
characterization of syngeneic monoclonal anti-idiotypic
antibodies against a monoclonal antibody that recognizes
the envelope glycoprotein haemagglutinin (H) of rinder-
pest virus. The main purpose of this study was the gen-
eration and analysis of the internal image of H protein in
the form of an anti-idiotypic antibody, which may have
the potential to elicit virus-specific immune responses
and may maintain the immunological memory. Anti-idio-
typic monoclonal antibody D9D8 (Ab2) was produced
against a monoclonal idiotypic antibody A12A9 (Ab1,
which had been generated earlier)4 for which the anti-
genic site on H protein lies between amino acid residues
527 and 556. We show that mimicry of the H antigen
by anti-idiotypic antibody D9D8 is associated with a
12-amino-acid sequence on its heavy-chain hypervariable
region. This sequence is partially homologous with the
epitope on H protein, which is conserved in the H pro-
tein of viruses in the morbillivirus genus. The anti-idio-
typic antibody was able to elicit antigen-specific B-cell
and T-cell responses when given as soluble or cell-bound
protein. In addition, the boosting of antigen-primed ani-
mals with anti-idiotypic B cells generates antigen-specific
memory B-cell and T-cell responses. We demonstrate that
an idiotypic–anti-idiotypic network of antigen-specific B
cells, which also involves T cells, exists in the body of
immunized animals. This network is capable of relaying
the memory in the absence of antigen to succeeding gen-
erations of B and T cells.
Materials and methods
Animals
BALB/c mice and Sprague Dawley rats were bred and
maintained in the Central Animal Facility, Indian Insti-
tute of Science, Bangalore, in accordance with the institu-
tional guidelines. Female mice, 8–12 weeks old, were used
in all experiments.
Cell lines
A12A9 (Ab1), a B-cell hybridoma cell line of BALB/c ori-
gin, was generated against the purified recombinant
haemagglutinin protein of rinderpest virus.15 The murine
myeloma cell line sp2/0 and, the hybridoma cell line
A12A9 (Ab1) and Ab2 cell line (D9D8) generated in this
work were maintained in Iscove’s modified Dulbecco’s
medium supplemented with 10% heat inactivated fetal
bovine serum (FBS) (Life Technologies, Grand Island,
NY), 2 mM/l L-glutamine, 100 U/ml penicillin (Gibco-
BRL, New York, NY), and 100 lg/ml streptomycin
(Gibco). P815 (H-2d) murine mastocytoma cells were cul-
tured in RPMI-1640 medium (Gibco-BRL) supplemented
with 5% FBS (Life Technologies). Sf-21 cells were main-
tained in TC-100 medium (Gibco-BRL) supplemented
with 10% FBS (Life Technologies). Baculovirus expressing
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full-length H protein as secretory protein16 was used to
infect these cells at a multiplicity of infection of 20 and
the secreted H protein was collected from the medium
and purified by immunoaffinity chromatography. The
purified H protein was used as a source of antigen.
Cytokines
All cytokine standards and cytokine-specific antibodies
were purchased from E-bioscience (San Diego, CA).
Recombinant murine IL-4 was purchased from Pharmin-
gen (San Diego, CA).
Peptides
Peptides were designed based on the amino acid sequence
homology of D9D8 and H protein. They were procured
from Peptron (Daejeon, South Korea). The purity of
peptides was > 90% by high-performance liquid chromato-
graphy analysis. The sequences of the peptides were
YYYPFKLPI (H-1), IYSTTGRLS (H-2), GSTYYPDSV
(VH), RLLIYLVSL (VL).
Immunization and hybridoma production
Three female 8-week-old BALB/c mice were injected
subcutaneously with monoclonal anti-haemagglutinin
hybridoma cells (secreting A12A9 antibody; 20 · 106)
irradiated at 3500 rads and boosted twice with the same
number of cells at a 1-week interval. Sera collected from
the immune mice were tested for the presence of anti-
idiotypic antibody. Hybridoma cells were generated by
polyethyleneglycol-mediated fusion of immune spleno-
cytes with Sp2/0 cells followed by two cycles of sub-
cloning by limiting dilution.17
Detection of anti-idiotypic antibody
The anti-idiotypic antibody was detected by enzyme-
linked immunosorbent assay (ELISA) employing purified
polyclonal anti-H antibody (200 lg/well) raised in rabbit.
The presence of anti-idiotypic antibody in culture super-
natants was also monitored by FACScan flow cytometry
(B&D, San Diego, CA) using monoclonal Ab1 cells bear-
ing surface immunoglobulin and anti-mouse IgG fluores-
cein isothiocyanate conjugate. The clone D9D8, which
consistently produced high titre antibodies as determined
by ELISA and fluorescence-activated cell sorting, was
chosen for further experiments and the isotype of this
clone was determined using an Isotype ELISA kit
(Boehringer-Mannheim, GmbH, Mannheim, Germany)
following the kit protocol. IgG for D9D8 was purified
from ascitic fluid by affinity chromatography on a protein
A–Sepharose 4B column (Pharmacia, Uppsala, Sweden).
The purity of the isolated immunoglobulin (> 99%) was
determined by sodium dodecyl sulphate polyacrylamide
gel electrophoresis.
Generation of anti-anti-idiotypic antibody (Ab3)
Sprague Dawley female rats (12 weeks old) were immun-
ized by two intraperitoneal injections of purified D9D8
(200 lg) in complete Freund’s adjuvant with a 1-week
interval. After 2 weeks, sera were collected and booster
was given with the same amount of antigen in incomplete
Freund’s adjuvant. The 2-week post-booster serum was
checked for the presence of anti-anti-idiotypic antibody
by ELISA.
Competitive ELISA
Purified Ab1 was biotinylated using ImmunoProbe
TM Bio-
tinylation Kit (Sigma, St. Louis, MO) following the
manufacturer’s instructions. Microtitre plates (high-bind-
ing, Costar, Cambridge, MA) were coated with 200 lg H
protein, blocked with 2% bovine serum albumin, reacted
with a mixture of 50 ll biotinylated Ab1 (A12A9)
(1 : 1000 dilution) and 50 ll varying concentrations Ab2
(10 lg to 001 lg) or control anti-bodies (normal mouse
IgG and purified X2A5, an isotype-matched non-specific
antibody). Following a 1-hr incubation, avidin–horserad-
ish peroxidase was added and colour was developed by
addition of H2O2 and o-phenylenediamine. The per cent
inhibition by Ab2 of the binding of Ab1 to antigen was
calculated by taking the optical density of the well con-
taining no competitor as 100%.
Polymerase chain reaction amplification and sequence
analysis of variable region of heavy and light chains
Cytoplasmic RNA was extracted from D9D8 hybridoma
cells (3 · 106 cells) by the TRIZOL method. Reverse tran-
scription and polymerase chain reactions were performed.
Variable regions of the heavy (VH) and light (VL) chains
of immunoglobulin were amplified in two different reac-
tions using IgG-specific primers (forward primer: TGAG
GAGACGGTGACCGTGGTCCCTTGGCCCC; reverse pri-
mer: AGGTSMARCTGCAGSAGTCWGG) and j-chain-
specific primers (forward primer: GACATTGAGCT
CACCCAGTCTCN; reverse primer: CTCGAGTTTGAGT
TCCAGCTTN), respectively. Polymerase chain reaction
products were subsequently cloned into pGEM-T EASY
(Promega, Madison, WI) vector and were sequenced by
standard DNA sequencing techniques. The amino acid
sequence of VH and VL was deduced from the nucleotide
sequence using a DNA-translate tool (http://www.
expasy.org/tools/dna.html). The VH and VL sequences
were aligned with the known sequence of H antigen using
the Global Alignment Program (GAP) algorithm18 to
check for homologous regions.
488  2007 Blackwell Publishing Ltd No claim to original Indian government works, Immunology, 120, 486–496
J. Vani et al.
Generation of a P815 cell line stably expressing H protein
P815 cells were plated in 60-mm tissue culture Petri plates
and transfected with 10 lg H-pFLAG-CMV-3 plasmid DNA
(Sigma) (harbouring a full-length H gene subcloned from
the pBluescript (PBS) vector16 into eukaryotic pFLAG cyto-
plasmic expression vector) in serum-free medium using lipo-
fectamine (Life Technologies). Stable cell lines were made
following the protocol mentioned in Nilsson and Nilsson.19
Positive clones (P815-H cells) were maintained in complete
medium containing 400 lg/ml of G418 (Calbiochem,
Lajolla, CA). Protein expression in the cells was confirmed
by fluorescence microscopy, sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis and enhanced chemilumines-
cence Western blotting of the cell lysates using H-protein-
specific rabbit polyclonal antibody and anti-flag antibody.
Lymphocyte proliferation assay
Responder T cells (T cells from H-protein-immune and
Ab2-immune mice) were isolated as described earlier
20
and were plated at a density of 5 · 105 cells/well in
96-well flat-bottomed tissue culture plates in the presence
of either P815-H cells, purified H protein, soluble Ab2 or
P815 cells pulsed with synthetic peptides derived from the
mimic regions of H protein, VH or VL. Anti-rinderpest
virus N-protein-specific monoclonal antibody and puri-
fied rinderpest virus P protein were used as negative
controls. Cells were cocultured for 72 hr and then pulsed
for 16 hr with [3H]thymidine (1 lCi/well). Cells were
harvested on glass fibre filters using a semi-automated cell
harvester (Nunc, Roskilde, Denmark). [3H]Thymidine
incorporation was measured in a liquid scintillation
spectrophotometer and T-cell proliferation was measured
as mean counts/min of triplicate wells. For recall response
experiments, lymphocytes isolated from H-protein-
immune and differentially boosted mice were restimulated
in vitro with purified H protein (50 lg/ml) and a prolif-
eration assay was carried out as described above.
Cytotoxic T-cell assay
Single cell suspensions from lymph nodes isolated from
H-protein-immune and differentially boosted mice were
seeded in complete medium at a concentration of 2 · 106
cells/well of 24-well plates. P815-H cells (1 · 106 cells/well)
irradiated at 4000 rads were used as antigen-presenting
cells. The cells were cocultured for 10 days in the presence
of antigen-presenting cells and IL-2 (100 units/ml). Viable
cells were harvested and were used as effector cells in a CTL
assay. Antigen-specific CTL activity was assessed employing
P815-H cells as targets at different effector : target ratios.
CTL activity was measured with a cytotoxic assay kit
(Roche, Mannheim, Germany) following the manufac-
turer’s instructions.
Cytokine ELISA
Splenocytes from the immune mice were incubated with
various restimulants for 72 hr as described above for cell
proliferation assays. Supernatants from the culture were
collected for cytokine assays. IL-2, IL-4 and interferon-c
(IFN-c) were assayed using cytokine ELISA kits (e-Bio-
science).
Intracellular cytokine staining
Lymph node cells from H-protein-immunized mice and
P815-H cells were cocultured for 4 hr. Brefeldin-A was
added at a final concentration of 10 lg/ml 6 hr later, cells
were harvested and after permeabilization with 05%
saponin, intracellular staining was performed using anti-
mouse IFN-c–biotin-conjugated antibody and streptavi-
din–phycoerythrin (Pharmingen).
Results
Anti-idiotypic antibody response in mice
There were 180 clones as a result of the fusion of Sp2/0
myeloma cells and splenocytes from BALB/c mouse
immunized with Ab1 (A12A9), of which 14 clones pro-
duced antibodies that reacted with Ab1. Two clones
(D9D8 and D9E6) secreting antibodies that reacted best
with Ab1 both in ELISA and flow cytometry were selected
for further study. Both produced antibodies of IgG heavy
and j light chain isotypes. The D9D8 hybridoma was
selected for all further studies.
Anti-anti-idiotypic antibody response
To test whether D9D8 Ab2 is an antigen mimic (Ab2b),
purified Ab2 protein was used to immunize rats. The
reactivity of rat serum with antigen H was measured in
ELISA. The results illustrated in Fig. 1 show that Ab3
made in rats reacts with the antigen and thus is similar to
Ab1. Thus, Ab2 D9D8 induces Ab3, which recognizes the
original antigen H, indicating that D9D8 is Ab2b.
Ab2 recognizes Ab1 from different animal species
D9D8 (Ab2) recognized antibodies made in different ani-
mal species against rinderpest virus infection or H protein
immunization (Table 1). These results confirmed that Ab2
is indeed a functional H protein mimic.
Anti-idiotypic antibody competes with H protein
for binding to idiotypic antibody
Ab2 (D9D8) inhibited the binding of Ab1 to antigen in a
dose-dependent manner (Fig. 2). D9D8 at a concentration
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of 10 lg/ml inhibited the binding of A12A9 to H protein
by 76% while the control antibodies did not cause any
significant inhibition over a range of concentrations. This
indicated that D9D8 has the functional epitope for Ab1,
which is similar to the epitope on H protein.
Sequence analysis of anti-idiotypic antibody
The sequences of VH and VL are given in Fig. 3(a).
Hypervariable regions (CDRs) and framework regions
(FRs) on these sequences were located using immuno-
globulin BLAST of NCBI (http://www.ncbi.nlm.nih.gov/
igblast/). The epitopic site on H protein for Ab1 was
mapped to the region between amino acids 525 and 556
employing deletion mutants of H protein. Alignment of
the Sec-H-epitope-containing sequence with that of D9D8
(Fig. 3b) using the global alignment programme (GAP)
indicated a significant homology with heavy chain CDR2.
Fifty-two per cent similarity and 48% identity were seen
between the epitopic region and CDR2 (amino acids 32–
54) of the D9D8 VH (in a 15-amino-acid stretch, nine
amino acids were identical and one was similar) while
between VL and the epitopic region 35% similarity and
28% identity were seen, corresponding to part of the
CDR2 and part of the FR2 regions (a two-amino-acid
similarity and a one-amino-acid identity).
Figure 1. Determination of D9D8 as Ab2b by ELISA. Plates were
coated with purified recombinant H protein (200 ng/well) and incu-
bated with rat sera (pre-immune, s; pre-boost, n and post-boost,
m) raised against purified Ab2 at different dilutions. Donkey anti-
rat–horseradish peroxidase was used as the secondary antibody. Data
shown are the average optical density (OD) of triplicate wells.
Table 1. Reactivity of purified Ab2 (D9D8) with heterologous sera
as the source of Ab1
1
Immunizing agent Species
Titre of Ab1
in immune
in sera2
Recombinant Baculo H protein
(soluble)
Cattle 64
H protein displayed on
recombinant extracellular
baculovirus
Cattle > 32
Recombinant baculo H protein
(membrane-bound form)
Rabbit 32
Peste des petits ruminants virus Goat3 > 64
Rinderpest virus Cattle4 > 32
1Microtitre plates were coated with 200 ng/well of Ab2 and dilutions
of H-specific immune sera from different sources was added.
2Data shown are titre (· 103) of Ab1 recognized by Ab2 and are cal-
culated from average optical density (OD) of triplicate wells on
comparison with OD of respective dilutions of pre-immune sera.
Normal rabbit, bovine and goat serum were used as controls and the
OD values of controls were subtracted from the experimental values.
3Hyper-immunized goats.
4Convalescent cattle.
Figure 2. Inhibition of Ab1 (A12A9) binding to Sec H by Ab2
(D9D8) in ELISA. Sec H protein 100 ng/well was the coating anti-
gen. Inhibition of binding of biotinylated A12A9 to Sec H was tested
in the presence of different concentrations of D9D8 (r). Normal
mouse IgG (d) and X2A5 (m), an isotype-matched control antibody
(purified) raised against rinderpest virus nucleocapsid protein, were
used as controls at the same concentrations. Data represent average
optical density (OD) of triplicate wells.
RFTISRDNAKNT LYLQMSSLKS EDTAMYYCAR DQGTTVVASR CRLS 
Figure 3. (a) Sequences of variable regions of heavy (VH) and light
(VL) chains of D9D8. (b) Alignment of homology regions between
VH/VL sequences and antigenic region carrying the epitope on
rinderpest virus H protein showing the ‘Internal Image’.
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Anti-idiotypic Ab immunization generates an
antigen-specific immune response
To test the generation of an antigen-specific T-cell
response elicited by anti-idiotypic antibody, T-cell prolif-
eration assays using T cells from anti-idiotypic-antibody-
immune mice with various in vitro restimulants were
performed. P815-H cells, which express H protein endo-
genously, were used as antigen-presenting cells and prolif-
eration of immune T cells was monitored (Fig. 4). The
proliferation was equally good, in response to soluble H,
although the immune animals had never been exposed to
the H protein. This response is 70% of the response gen-
erated when H-immunized splenocytes were restimulated
with P815-H cells (data not shown). No cross-reaction
was observed when immune cells were restimulated with
irrelevant antibody or irrelevant protein. As can be seen
from thymidine incorporation (Fig. 5a), the Ab2 immune
cell population had substantial levels of antigen-primed T
cells by virtue of selective proliferation of T cells by the
antigen mimic present on the anti-idiotypic B cells. The
cells were also stimulated with synthetic peptides from
the mimic regions on H and VH and VL of Ab2. Cells sti-
mulated with the soluble H as well as H-derived synthetic
peptide (IYSTTGRLS) exhibited greater proliferation, as
shown by increased thymidine incorporation when com-
pared to Ab2-stimulated cells. The presence of idiotypic
cascade was monitored using Ab1 for in vitro restimula-
tion, which also showed a substantial level of cell pro-
liferation. Thus, it is evident that antigen-specific and
idiotype-specific T cells are generated in vivo and coexist,
probably as a result of the operation of an idiotypic–anti-
idiotypic network.
When cytokine patterns were evaluated, it was observed
that in vitro stimulation of Ab2 immune cells with soluble
Ab2 (Fig. 5b) produced high levels of IL-2 and IFN-c. H
protein and H-2 peptide (IYSTTGRLS) restimulated cells
also secreted relatively higher amounts of IFN-c and IL-2,
consistent with the proliferation assay results.
Generation of B- and T-cell memory response
after boosting of antigen-H-primed animals with
anti-idiotypic B cells
To evaluate the role of anti-idiotypic B cells in the main-
tenance of B-cell and T-cell memory, mice were immun-
Figure 4. Proliferation of Ab2 immune splenocytes (5 · 105 cells/
well) on in vitro restimulation by P815 cells stably expressing H
(stippled bars) and wild-type P815 (striped bars) cells. The data
shown are the mean counts/min of triplicate wells.
Figure 5. (a) Proliferation of Ab2 immune splenocytes on in vitro
restimulation with purified Ab1, H protein, H-specific synthetic pep-
tides [H-1, H-2], VH peptide and VL peptide (10 lg/ml) derived
from the homology regions. The data shown are the mean counts/
min of triplicate wells. (b) IL-2 and IFN-c production by in vitro
restimulated Ab2 immune splenocytes in response to stimulation by
full-length antigen and antigen-derived peptides (8 lg/ml). The
results shown are representative of three independent experiments.
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ized with H protein in Freund’s complete adjuvant and,
after 72 days, were boosted with H protein or irradiated
H-specific idiotypic B cells or anti-idiotypic B cells. The
memory T-cell recall response was monitored after 1 week
of booster, using the splenocytes of these mice and
in vitro proliferation assay, cytotoxic assay and cytokine
response. The results showed that splenocytes from anti-
idiotypic B-cell-boosted mice exhibited a secondary
immune response similar to those mice that were boosted
with antigen (Fig. 6a), whereas the cells from animals that
did not receive booster immunization showed a smaller
antigen-specific proliferative response. CD8+ T cells from
the lymph node cells of boosted mice, in vitro enriched in
the presence of P815-H cells and IL-2, when used as
effector cells, recognized the antigen-presenting cells and
exhibited killing activity. Cells from H-boosted, anti-idio-
type-boosted mice showed the same levels of cytotoxicity
followed by cells from idiotype-boosted mice (Fig. 6b).
CD8+ T cells from the lymph node cells of boosted mice
secreted IFN-c after in vitro restimulation with P815-H
cells, as shown by the intracellular cytokine staining
(Fig. 6c). On restimulation with H protein, the spleno-
cytes secreted high levels of IFN-c and considerable
amount of IL-2, whereas IL-4 was not detected in signi-
ficant amounts (Fig. 6d). The memory B-cell recall
response was monitored by checking the presence of
H-specific antibodies in the serum from immune animals.
Serum from mice boosted with anti-idiotypic cells showed
high titres of H-specific antibody, which was more than
that in antigen-boosted mice (Table 2). Cumulatively,
Figure 6. Generation of memory T-cell response by anti-idiotypic B cells. Mice were immunized with H protein (50 lg/mouse). After 72 days, a
booster dose was given with H protein, irradiated H-specific idiotypic B cells (Id; 2 · 107), anti-idiotypic B cells (anti-Id; 2 · 107), normal B cells
(2 · 107) or only PBS in Freund’s incomplete adjuvant. After 1 week (a) in vitro proliferation of splenocytes was performed in the presence of H
protein (50 lg/ml). Data shown are the mean counts/min of triplicate wells. The result shown is representative of three independent experiments
(b) Draining lymph nodes were collected from the above mentioned immune mice 1 week after booster. Lymph node cells (4 · 106 cells/well)
(boosted with antigen, r; anti-Id, n; Id, m; normal cells, s) were restimulated in vitro with irradiated P815-H cells and IL-2 (100 units/ml) as
mentioned in the Materials and methods. A CTL assay was performed using these as effector cells and P815-H cells as targets. (c) Lymph node
cells (4 · 106 cells/well) were restimulated in vitro with P815 cells expressing H protein or P815 cells (5 · 106 cells/well) transfected with vector
alone for 8 hr in complete medium. Brefeldin-A was added in the last 6 hr. Surface staining for CD8 and intracellular cytokine staining for IFN-c
were performed and analysed by fluorescence-activated cell sorting. The results shown are the percentages of CD8 and IFN-c double-positive cells.
(d) From the in vitro proliferated splenocyte cultures (crossed bar, H; striped bar, anti-Id antibody; dotted bar, Id antibody; closed dotted bar,
normal cells; open bar, PBS-boosted) cell-free supernatants were collected and were assayed for IL-2, IL-4 and IFN-c. Data shown are means of
triplicate wells and the amount of cytokine (pg/ml) was calculated using cytokine standards.
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boosting of antigen-immunized mice with anti-idiotypic
B cells produced a secondary response comparable to that
upon antigen boosting. Boosting with normal B cells did
not result in a secondary response in animals demonstra-
ting the specificity of recall response.
Discussion
Anti-idiotypic antibodies with homologous sequences to
specific regions of the immunogenic proteins of infectious
organisms have been shown to functionally mimic these
epitopes and to induce protective immune responses;21,22
they have been used in experimental systems as surrogate
vaccines against several bacterial,23 viral22,24–27 and parasi-
tic organisms21,28 and as several tumour-associated anti-
gens.13,29 It has been shown that a murine Ab2 mimicking
a peptide of hepatitis B surface antigen expressed epitopes
for both B and T cells. The Ab2 appeared to activate T
cells through the same mechanisms as used by the nom-
inal antigen.30 Moreover, the Ab2 elicited cellular and
humoral responses in an out-bred strain of mice and also
in a strain that was not responsive to the nominal anti-
gen. Thus, the authors have postulated that Ab2 vaccines
containing specific epitopes capable of stimulating T and
B cells might well induce a specific cellular and humoral
immunity against the nominal antigen in a genetically
diverse human population that has never been confronted
with the antigen.
Operation of the idiotypic network has been postulated
in the control of autoimmune disease in animal models
and patients.31–35 Several studies36,37 have shown that
iodiotypic networks have important roles in the control
of a host’s response to an antigen: regulating, enhancing
or suppressing feedback mechanisms. Monoclonal anti-
idiotype antibodies fused to granulocyte–macrophage col-
ony-stimulating factor have been shown to be capable of
breaking tolerance to carcinoembryonic antigen in carcino-
embryonic antigen transgenic mice.12 Antigen-specific
protective T-cell and B-cell immunity by an amplifying
anti-idiotypic response in multiple myeloma patients has
also been demonstrated.38
The role of B cells in the presentation of idiotype to T
cells has been shown in a transgenic mouse model where
B cells present self-peptides in the absence of conven-
tional antigen.39 For the generation and regulation of spe-
cific immunity by anti-idiotypic and anti-idiotype-derived
peptidomimics, we postulate four possible mutually non-
exclusive pathways.
(1) Antigen-specific idiotypic B cells, as well as their
complementary anti-idiotypic B cells (carrying immu-
noglobulins on their surface that are specifically react-
ive against the idiotypic determinant on the antigen-
specific B cells) can undergo terminal differentiation
into plasma cells upon recognition and contact with
the idiotypic determinants of the B-cell membrane-
bound immunoglobulin.40 Regulation of these cells is
brought about by the engagement of their B-cell anti-
gen receptor, leading to proliferation, differentiation
and/or programmed cell death.41,42
(2) Anti-idiotypic B cells can present peptide mimics of
antigen to T helper and T cytotoxic cells thus priming
them in the absence of antigen. Cytotoxic T cells com-
plementary to the idiopeptide may recognize the cog-
nate antigen or the idiopeptides derived from the
antigen mimic or the anti-idiotypic immunoglobulin
and kill the B cells presenting such idiopeptides.43–46
(3) Receptor-mediated endocytosis followed by endo-
somal cleavage of the idiotype–anti-idiotype complex
can take place and peptides generated in the process
can then be loaded onto MHC class II molecules and
presented to CD4+ T cells, switching on the T-cell
and B-cell interactive idiotypic cascade.
(4) Apart from these, the idiopeptides can also be proc-
essed and presented in vivo by dendritic cells and by fol-
licular dendritic cells in an MHC-restricted manner.6
To provide experimental evidence that supports the
role played by the anti-idiotypic B cells in the generation
of antigen-specific B-cell and T-cell memory responses
and the regulation of B-cell homeostasis, it was impera-
tive to study a single B-cell clone that was specific for a
well-defined antigen. However, the isolation of such B-cell
populations is difficult because of the presence of small
numbers of idiotypic and anti-idiotypic B cells, which
limits their enrichment from the total cell population.
The second alternative, which was ruled out, was the
use of antigen-primed primary B-cell clones maintained
in vitro, which cease to proliferate after a finite number
of divisions in tissue culture. Use of Epstein–Barr-virus-
transformed B-cell cultures was avoided because such cell
populations are expected to present viral antigens that
shift the experimental set-up away from natural condi-
tions. We have therefore, used anti-idiotypic B-cell hybri-
doma as the surrogate B cells in this study.
Table 2. Generation of memory B-cell response by anti-idiotypic B
cells as detected by measuring the amount of secreted antibody1
Antigen used for
booster immunization
Antibody titre
(· 103)2
H protein > 16
Anti-idiotypic B cells > 64
Idiotypic B cells 32
Irrelevant B cells < 2
None < 2
1Dilutions of sera collected from mice (as mentioned in legend of
Fig. 6) were reacted with antigen (200 lg/well of H protein).
2Data shown as titre are from the average optical density of triplicate
wells normalized with readings for pre-immune sera.
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In the present work, we have shown that on adoptive
transfer of anti-idiotypic B cells carrying peptidomimics,
antigen-specific B-cell and T-cell memory can be perpetu-
ated. We have shown that anti-anti-idiotypic CD4+ and
CD8+ T cells are generated in the body after the transfer
of monoclonal anti-idiotypic B cells in syngeneic mice.
We observed that when Ab1 was introduced as a restimu-
lant, significant amounts of cell proliferation occurred.
This could be the result either of the anti-idiotypic cells
used for primary immunization persisting in the body at
the time of detection of anti-anti-idiotypic T and B cells,
or of the generation of anti-anti-anti-idiotypic cells,
which is the next stage in the cascade. The results show
that idiotypic and anti-idiotypic T and B cells can coexist
in the body and may form a dynamic system as a B-cell
and T-cell idiotypic network. The anti-idiotype-specific
CD4+ and CD8+ T cells did proliferate relatively less effi-
ciently against the synthetic peptides derived from anti-
idiotypic antibody sequences, which is expected because
the fragments of anti-idiotypic antibody may contain
many fewer processed and presented epitopes compared
to H protein or full-length anti-idiotypic antibody.
Furthermore, boosting with anti-idiotypic B cells gener-
ated antigen-specific memory T-cell and B-cell immune
responses. This could be operative through direct B-cell–
B-cell interactions or through presentation of idiopeptides
by phagocytic antigen-presenting cells after phagocytosis
of idiotypic T and B cells. The anti-idiotypic B and T cells
generated after immunization with antigen are directed
against antigen-reactive T cells, implying that the presence
of an idiotypic B-cell–anti-idiotypic B-cell cascade is nat-
ural to the system after infection or vaccination.
Significant levels of IFN-c were secreted by Ab2-primed
T cells upon in vitro restimulation with H, H-derived
peptides or Ab2, although IL-4 was not detected, suggest-
ing that CD4+ cells induced by H were probably T helper
type 1. Traditionally CD4+ T cells function as helper cells
for antibody production. Therefore D9D8 immunization/
vaccination may prime T helper type 1 cells, which in
turn may induce cytotoxic T-cell proliferation by secre-
tion of cytokines such as IFN-c.
T-cell epitopes derived from the naturally processed
self-peptides are the peptides most abundantly presented
by MHC,47,48 more than the peptides from pathogens.
The anti-idiotypic antibodies, being self-generated, thus
have more chance to act as elicitors of effective antigen-
specific T-cell responses. The observed cytotoxic and
lymphoproliferative responses indicate that anti-idiotypic
B cells (Jerne cells) stimulate both T helper and T cyto-
toxic cells by virtue of their ability to present recycled or
regurgitated peptidomimics of antigen to T helper cells
through class II MHC and de novo synthesized peptido-
mimics of antigens to CTLs through class I MHC. Thus,
the T-cell memory response can be perpetuated by anti-
idiotypic Jerne B cells and these findings lend support to
the earlier proposed relay hypothesis for the perpetuation
of immunological memory.2 The results provide a mech-
anism for the maintenance of both idiotypic and anti-
idiotypic B cells, which are generated in a cyclic fashion
as has been proposed earlier.2 This also means that B-cell
and T-cell memory of longer duration could arise as the
idiotypic cascade is triggered. Based on the structural
information and on the recent study of altered peptide
ligands,49,50 we propose that peptidomimics in the CDRs
of anti-idiotypic B cells, which may not be completely
homologous to the original antigen peptide but which
carry the structural complementarities,51 will trigger idio-
typic antigen-specific T cells.
In summary, the antibody repertoire contains the anti-
genic universe with an innate ability to react with the B
and T cells of the self. The anti-idiotypic antibody func-
tions as a surrogate antigen and idiotypic selection
ensures that relevant B-cell clones are always maintained.
The peptidomimics derived as a result of the degradation
of anti-idiotypic antibody bring about idiotypic selection
and activation of cognate CD4+ and CD8+ T cells, so an
elevated population of activated T cells, the memory T
cells, is always maintained. Thus the idiotypic selection
of B cells and T cells containing the already randomly
rearranged and mutated antibody and T-cell receptor
genes ensures a specific memory response. The duration
of the memory is dependent on the strength of the inter-
action of idiotypic and anti-idiotypic B-cell receptors and
on the effective presentation of idiopeptides (peptido-
mimics) to cognate T cells.
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